Gate2brain
Biotech company improving drug delivery to the brain using a peptide-based patented technology.
Employees
Company register number
B01697564
- biotechnology
- horizon europe
- dt and ls
- woman founder
- spinout
- biotech and pharma
- eit ecosystem
- neurology
- drug development
- eit health
- non-invasive medical devices and treatments
- eit supernovas
- eicfund
- bootcamps (eit health)
- microbiology
- caixa impulse (eit health)
- bootcamp 2021 (eit health)
- caixa impulse 2019 (eit health)
| EUR | 2020 | 2021 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| % EBITDA margin | - | (827 %) |
| Profit | 0000 | 0000 |
| % profit margin | - | (180 %) |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
More about Gate2brain
EditMade with AI
Developer of a novel technology platform intended for the delivery of therapeutics across biological barriers. The company focuses on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier using a radically innovative peptide-based patented technology platform, enabling the medical industry to cure rare pediatric cancers.
Keywords: Pharmaceuticals and Biotechnology, Anticancer Drug Delivery, Biotech Company, Brain Disease Treatment, Drug Delivery System, Drug Delivery Technology, Pediatric Cancer.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.